Thyroid gland, shortly histology and detail physiology with relevant flow chart and diagram, and clinical physiology

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching Images

thyroid gland histology follicle colloid

This is a light micrograph of thyroid gland tissue prepared for histopathology and stained with Hematoxylin and Eosin (H&E). The sample reveals multiple spherical to irregular follicles of varying size separated by wispy fibrous septa. The colloid-filled lumens are pink to pale pink, while the surrounding follicular epithelium is a uniform single layer of cuboidal to low-columnar cells with round to oval nuclei and inconspicuous nucleoli. No nuclear grooves, inclusions, or pseudoinclusions characteristic of papillary carcinoma are evident. The stromal background is relatively scant with no dense lymphocytic infiltrate or Hurthle cell metaplasia apparent. The architecture is reminiscent of normal thyroid parenchyma or benign nodular colloid goiter pattern, where follicle size varies and colloid predominates. There are no mitotic figures or cytologic atypia observed. This image demonstrates classic histology of endocrine gland tissue with preserved colloid and regular follicle lining, suitable as reference for normal thyroid architecture in educational, diagnostic, and research contexts. Clinically, such histology supports benign thyroid pathology when correlated with imaging and labs. In malignant differentials, absence of papillary nuclear features or tall columnar cells argues against papillary thyroid carcinoma; however, definitive diagnosis should consider capsule invasion and margin status in surgical specimens.

This is a light micrograph of thyroid gland tissue prepared for histopathology and stained with Hematoxylin and Eosin (H&E). The sample reveals multiple spherical to irregular follicles of varying size separated by wispy fibrous septa. The colloid-filled lumens are pink to pale pink, while the surrounding follicular epithelium is a uniform single layer of cuboidal to low-columnar cells with round to oval nuclei and inconspicuous nucleoli. No nuclear grooves, inclusions, or pseudoinclusions characteristic of papillary carcinoma are evident. The stromal background is relatively scant with no dense lymphocytic infiltrate or Hurthle cell metaplasia apparent. The architecture is reminiscent of normal thyroid parenchyma or benign nodular colloid goiter pattern, where follicle size varies and colloid predominates. There are no mitotic figures or cytologic atypia observed. This image demonstrates classic histology of endocrine gland tissue with preserved colloid and regular follicle lining, suitable as reference for normal thyroid architecture in educational, diagnostic, and research contexts. Clinically, such histology supports benign thyroid pathology when correlated with imaging and labs. In malignant differentials, absence of papillary nuclear features or tall columnar cells argues against papillary thyroid carcinoma; however, definitive diagnosis should consider capsule invasion and margin status in surgical specimens.

This is a light microscopy histology image of thyroid gland tissue prepared with a Romanowsky-type stain (e.g., Diff-Quik/Wright-Giemsa). The specimen shows normal-appearing follicular epithelium arranged in intact macrofollicles with abundant colloid occupying the luminal spaces. Follicular cells are evenly spaced with uniform, round to oval nuclei and scant to moderate cytoplasm, consistent with well-differentiated thyroid epithelium. The colloid background is pale blue and prominent, reflecting thyroglobulin-containing material released from follicles. The architectural pattern emphasizes large follicle units with a single layer of cuboidal to low-columnar epithelium surrounding expansive colloid pools. No prominent nuclear features of papillary carcinoma are evident, and there is no marked cellular atypia or mitotic activity in the visible fields. This image illustrates classic histology of benign thyroid tissue or colloid-rich goiter, useful for teaching follicular morphologies, thyroid folliculogenesis, and colloid dynamics. Clinically, such samples are evaluated in the context of thyroid nodules and goiter workups, with correlation to serum thyroid function tests and, when applicable, ultrasound or FNA findings. Potential educational uses include cytology-histology correlation, differential diagnosis of thyroid disease, and artifact recognition in Romanowsky-stained preparations. Images are suitable for medical education, pathology review, and database indexing. Correlative data improve student comprehension and diagnostic recall greatly.

This is a light microscopy histology image of thyroid gland tissue prepared with a Romanowsky-type stain (e.g., Diff-Quik/Wright-Giemsa). The specimen shows normal-appearing follicular epithelium arranged in intact macrofollicles with abundant colloid occupying the luminal spaces. Follicular cells are evenly spaced with uniform, round to oval nuclei and scant to moderate cytoplasm, consistent with well-differentiated thyroid epithelium. The colloid background is pale blue and prominent, reflecting thyroglobulin-containing material released from follicles. The architectural pattern emphasizes large follicle units with a single layer of cuboidal to low-columnar epithelium surrounding expansive colloid pools. No prominent nuclear features of papillary carcinoma are evident, and there is no marked cellular atypia or mitotic activity in the visible fields. This image illustrates classic histology of benign thyroid tissue or colloid-rich goiter, useful for teaching follicular morphologies, thyroid folliculogenesis, and colloid dynamics. Clinically, such samples are evaluated in the context of thyroid nodules and goiter workups, with correlation to serum thyroid function tests and, when applicable, ultrasound or FNA findings. Potential educational uses include cytology-histology correlation, differential diagnosis of thyroid disease, and artifact recognition in Romanowsky-stained preparations. Images are suitable for medical education, pathology review, and database indexing. Correlative data improve student comprehension and diagnostic recall greatly.

Searching Images

hypothalamic pituitary thyroid axis diagram TRH TSH

This pathophysiology diagram illustrates the Hypothalamic-Pituitary-Thyroid (HPT) axis, comparing normal physiological conditions with the alterations observed during prolonged critical illness. The 'Normal conditions' section shows the standard cascade: the Hypothalamus secretes TRH, which stimulates the Pituitary to release TSH, leading the Thyroid gland to produce T4 and T3. These hormones reach target cells via TH binding globulins for hormone conversion and uptake, with a negative feedback loop inhibiting TRH and TSH secretion. In contrast, the 'Prolonged critical illness' section details the central and peripheral suppression of the axis. Key pathological features include: upregulation of T4 to T3 conversion in the hypothalamus (inhibiting TRH release), suppression of pulsatile TSH secretion by the pituitary, reduced thyroid hormone secretion, and depression of thyroid function at the tissue level. Peripheral mechanisms shown include increased conversion to inactive rT3 and altered hormone uptake. This comparison illustrates the endocrine maladaptation typical of Non-Thyroidal Illness Syndrome (NTIS) in intensive care settings.

This pathophysiology diagram illustrates the Hypothalamic-Pituitary-Thyroid (HPT) axis, comparing normal physiological conditions with the alterations observed during prolonged critical illness. The 'Normal conditions' section shows the standard cascade: the Hypothalamus secretes TRH, which stimulates the Pituitary to release TSH, leading the Thyroid gland to produce T4 and T3. These hormones reach target cells via TH binding globulins for hormone conversion and uptake, with a negative feedback loop inhibiting TRH and TSH secretion. In contrast, the 'Prolonged critical illness' section details the central and peripheral suppression of the axis. Key pathological features include: upregulation of T4 to T3 conversion in the hypothalamus (inhibiting TRH release), suppression of pulsatile TSH secretion by the pituitary, reduced thyroid hormone secretion, and depression of thyroid function at the tissue level. Peripheral mechanisms shown include increased conversion to inactive rT3 and altered hormone uptake. This comparison illustrates the endocrine maladaptation typical of Non-Thyroidal Illness Syndrome (NTIS) in intensive care settings.

A two-part medical illustration depicting the pathophysiology of the Hypothalamic-Pituitary-Thyroid (HPT) axis and cellular thyroid hormone action. Section (a) shows the systemic HPT axis, beginning with the cerebral cortex and hypothalamus. The hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the pituitary gland to secrete thyroid-stimulating hormone (TSH). TSH subsequently acts on the thyroid gland to stimulate the production of T4 and T3 hormones, which exert negative feedback on the hypothalamus and pituitary. Section (b) details the intracellular mechanism of action within a target cell. T4 and T3 enter the cell via thyroid hormone transporters. In the cytoplasm, deiodinases (D1/D2) convert T4 to T3, while D3 converts T4 to inactive reverse T3 (rT3). T3 enters the nucleus, binding to the thyroid hormone receptor (TR) which heterodimerizes with the retinoid X receptor (RXR). This complex binds to the thyroid hormone response element (TRE) on DNA, displacing corepressors and recruiting coactivators to initiate gene transcription (mRNA) and subsequent protein synthesis. The diagram also highlights potential sites of endocrine disruption (e.g., by Tributyltin/TBT), including receptor inhibition and deiodinase interference.

A two-part medical illustration depicting the pathophysiology of the Hypothalamic-Pituitary-Thyroid (HPT) axis and cellular thyroid hormone action. Section (a) shows the systemic HPT axis, beginning with the cerebral cortex and hypothalamus. The hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the pituitary gland to secrete thyroid-stimulating hormone (TSH). TSH subsequently acts on the thyroid gland to stimulate the production of T4 and T3 hormones, which exert negative feedback on the hypothalamus and pituitary. Section (b) details the intracellular mechanism of action within a target cell. T4 and T3 enter the cell via thyroid hormone transporters. In the cytoplasm, deiodinases (D1/D2) convert T4 to T3, while D3 converts T4 to inactive reverse T3 (rT3). T3 enters the nucleus, binding to the thyroid hormone receptor (TR) which heterodimerizes with the retinoid X receptor (RXR). This complex binds to the thyroid hormone response element (TRE) on DNA, displacing corepressors and recruiting coactivators to initiate gene transcription (mRNA) and subsequent protein synthesis. The diagram also highlights potential sites of endocrine disruption (e.g., by Tributyltin/TBT), including receptor inhibition and deiodinase interference.

Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

Graves disease exophthalmos goiter clinical photo

Searching PubMed

"thyroid function" AND physiology

Thyroid Gland: Histology, Physiology, and Clinical Correlations

1. Histology (brief)

The thyroid is enclosed by a thin fibrous capsule and organized into thousands of follicles - the functional unit of the gland.
  • Follicular cells (thyrocytes): A single layer of cuboidal-to-low-columnar epithelial cells surrounding a central lumen. They become taller/columnar when hyperactive (TSH-stimulated) and flatten when inactive.
  • Colloid: The pink, proteinaceous material filling the follicular lumen, composed mainly of thyroglobulin - the storage form of thyroid hormone.
  • Parafollicular (C) cells: Neural-crest-derived cells scattered singly or in clusters between follicles (concentrated at the junction of the upper 1/3 and lower 2/3 of each lobe). They secrete calcitonin, unrelated to the iodine-handling machinery of follicular cells, and are the cell of origin of medullary thyroid carcinoma.
  • Follicle size varies (small, active follicles vs. large, colloid-distended quiescent ones), and this variation is normal.
Thyroid histology showing follicles with colloid
Normal thyroid parenchyma: follicles of varying size lined by cuboidal epithelium, filled with pink colloid. - Pathology teaching image

2. Detailed Physiology

A. Hormone synthesis and secretion (step-by-step)

  1. Iodide trapping: Dietary iodide (need ≥100 μg/day) is actively transported into the thyrocyte across the basal membrane by the sodium-iodide symporter (NIS), which co-transports Na⁺ (down its gradient, maintained by Na⁺/K⁺-ATPase) with I⁻ (against its gradient). The gland concentrates iodide 20-40x plasma levels. NIS is stimulated by TSH.
  2. Iodide efflux into colloid: Iodide moves to the apical membrane and exits into the follicular lumen, aided by the transporter pendrin (mutated in Pendred syndrome: goiter + sensorineural deafness).
  3. Organification: At the apical border, thyroid peroxidase (TPO) oxidizes iodide to iodine and attaches it to tyrosine residues on thyroglobulin (a large glycoprotein with ~123 tyrosines, only 4-8 of which get iodinated), forming monoiodotyrosine (MIT) and diiodotyrosine (DIT).
  4. Coupling: TPO couples two iodotyrosines within the thyroglobulin backbone: MIT + DIT → T3; DIT + DIT → T4. Hormone remains bound within thyroglobulin, stored in colloid - a reservoir large enough to supply the body for ~2 months even without dietary iodide.
  5. Release: On TSH stimulation, thyrocytes endocytose colloid, fuse it with lysosomes, and proteolytically cleave thyroglobulin, releasing free T4 (~90% of secreted hormone) and T3 (~10%) into the circulation. Leftover MIT/DIT are deiodinated and the iodine recycled.
Thyroid hormone synthesis diagram - NIS, TPO, thyroglobulin

B. Flow chart - Hypothalamic-Pituitary-Thyroid (HPT) axis

Cerebral cortex / stress, cold, other stimuli
            │
            ▼
      HYPOTHALAMUS  →  releases TRH (thyrotropin-releasing hormone)
            │
            ▼  (portal vessels)
  ANTERIOR PITUITARY (thyrotrophs)  →  releases TSH (thyroid-stimulating hormone)
            │
            ▼  (systemic circulation)
      THYROID GLAND (follicular cells)
            │  TSH binds TSH-receptor → ↑NIS, ↑TPO, ↑colloid endocytosis
            ▼
     Secretes T4 (~90%) + T3 (~10%) into blood
            │
            ▼
  Peripheral tissues (liver, kidney, muscle, brain):
     T4 --5'-deiodinase (D1/D2)--> T3 (active form)
     T4 --5-deiodinase (D3)-----> reverse T3 (inactive)
            │
            ▼
  T3 binds nuclear Thyroid Hormone Receptor (TR-α/β) → heterodimerizes with RXR
  → binds Thyroid Response Elements (TRE) on DNA → alters gene transcription
            │
            ▼
   Metabolic / developmental effects on virtually every tissue
            │
            └──────── NEGATIVE FEEDBACK ────────┐
                 (T4/T3 suppress TRH & TSH release)
HPT axis and thyroid hormone action at the cellular level
(a) Systemic HPT axis with negative feedback. (b) Cellular mechanism: T4→T3 conversion by deiodinases, nuclear receptor binding, and gene transcription.

C. Transport and peripheral metabolism

  • Circulating T4/T3 are >99% bound to thyroxine-binding globulin (TBG), transthyretin, and albumin; only the free fraction is biologically active.
  • T4 is largely a prohormone; peripheral 5'-monodeiodination (D1 in liver/kidney, D2 in pituitary/brain/brown fat) converts it to the far more potent T3. Alternative deiodination (D3) produces biologically inactive reverse T3 (rT3) - upregulated in illness/starvation ("non-thyroidal illness/euthyroid sick syndrome"), a mechanism for tissue energy conservation.

D. Mechanism and systemic effects of thyroid hormone

T3 enters cells, and in the nucleus the T3-TR-RXR complex regulates transcription of genes controlling:
  • Basal metabolic rate: ↑O2 consumption, heat production, mitochondrial biogenesis (calorigenic effect).
  • Cardiovascular system: ↑heart rate and contractility (↑α-myosin heavy chain, SERCA, β-adrenergic receptors), ↓systemic vascular resistance from cutaneous vasodilation, ↑cardiac output.
  • Nervous system: essential for CNS maturation (cerebral cortex, basal ganglia, cochlea) in fetal/neonatal life; in adults, modulates mentation and catecholamine sensitivity.
  • Growth and skeletal maturation: synergizes with growth hormone; essential for normal bone growth and epiphyseal maturation.
  • Metabolism: ↑carbohydrate absorption and turnover, ↑lipolysis/cholesterol clearance, ↑protein synthesis and degradation (net catabolic in excess).
  • Skin/connective tissue: in hypothyroidism, glycosaminoglycan accumulation causes myxedema (puffy, non-pitting skin).
  • Reproduction: required for normal menstrual cyclicity and fertility, though not directly metabolically active on the uterus.

3. Clinical Physiology

DisruptionMechanismClinical picture
Iodine deficiencyInsufficient substrate for organification → ↓T3/T4 → loss of feedback → ↑TSH → gland hyperplasiaEndemic goiter, hypothyroidism
Autoimmune thyroiditis (Hashimoto)Anti-TPO/anti-thyroglobulin antibodies destroy follicular cellsPrimary hypothyroidism: fatigue, cold intolerance, weight gain, bradycardia, myxedema, ↑TSH/↓fT4
Graves diseaseTSH-receptor stimulating antibodies (TSI) mimic TSH, driving continuous NIS/TPO activity independent of feedbackThyrotoxicosis: tachycardia, weight loss, heat intolerance, tremor, goiter, ophthalmopathy; ↓TSH/↑fT4-fT3
Toxic nodular goiter / adenomaAutonomous, TSH-independent hormone secretion from a noduleHyperthyroidism with suppressed TSH, focal uptake on scintigraphy
Pendred syndromePendrin defect impairs iodide efflux to colloidGoiter + sensorineural hearing loss, mild hypothyroidism
Congenital NIS defectFailure of iodide trappingCongenital hypothyroidism (screened at birth to prevent cretinism/intellectual disability)
Non-thyroidal illness (sick euthyroid) syndromeCritical illness ↑D3 activity, converting T4 preferentially to inactive rT3; central TRH/TSH suppressionLow T3, variably low T4, inappropriately normal/low TSH - a physiologic adaptation, not true hypothyroidism
Amiodarone-induced thyroid dysfunctionHigh iodine load from the drug can precipitate either Jod-Basedow hyperthyroidism (autonomous tissue) or Wolff-Chaikoff hypothyroidism (excess iodide transiently blocks organification)Either thyrotoxicosis or hypothyroidism depending on gland reserve
Hypothalamic-pituitary-thyroid axis suppression in critical illness
Normal HPT axis (left) vs. its suppression in prolonged critical illness (right), illustrating central and peripheral adaptation.
Key labs to remember: TSH is the single most sensitive screening test for primary thyroid disease because of the log-linear feedback relationship between fT4 and TSH - small changes in free T4 produce large, easily detectable changes in TSH.
Sources: Ganong's Review of Medical Physiology 26E; Harrison's Principles of Internal Medicine 22E, Ch. 394; Cummings Otolaryngology Head & Neck Surgery, "Physiology of the Thyroid Gland"; Sabiston Textbook of Surgery, "Thyroid Histology and Physiology."
A recent genetic meta-analysis (Sterenborg et al., Nature Communications 2024, PMID 38291025) confirms causal links between thyroid function variation and cardiovascular and metabolic outcomes, reinforcing the textbook physiology above rather than contradicting it - no major updates to core mechanisms are indicated.
This is a shared conversation. Sign in to Orris to start your own chat.